Highlights The Biotech Growth Trust PLC

Stocks

BIOG

GB0000385517

Investment Trusts

Market Closed - London S.E. Other stock markets 16:35:29 12/06/2026 BST			5-day change	1st Jan Change
1,298.00 ^GBX	+2.85%		+3.51%	+8.17%

06-03	EARNINGS AND TRADING: Vaultz Capital ousts CEO Benz, promotes Wood	AN
06-03	The Biotech Growth Trust PLC Reports Earnings Results for the Full Year Ended March 31, 2026	CI

Highlights

06-03	EARNINGS AND TRADING: Vaultz Capital ousts CEO Benz, promotes Wood	AN
06-03	The Biotech Growth Trust PLC Reports Earnings Results for the Full Year Ended March 31, 2026	CI
05-06	BIOG's investee Esperion bought by ArchiMed for USD1 billion	AN
05-01	The Biotech Growth Trust plc Archimed to acquire Biog Portfolio Company, Esperion Therapeutics.	RE
05-01	Archimed to Acquire Biotech Growth Trust Portfolio Co Esperion for $1 Billion	MT
12-22	The Biotech Growth Trust Biomar Pharmaceuticals to acquire Biog portfolio company, Amicus Therapeutics	RE
11-20	Biotech Growth Trust says while outlook is encouraging, challenges remain	RE
11-20	The Biotech Growth Trust PLC Reports Earnings Results for the Half Year Ended September 30, 2025	CI
11-14	The Biotech Growth Trust PLC commences an Equity Buyback Plan for 2,710,338 shares, representing 14.90% of its issued share capital, under the authorization approved on November 12, 2025.	CI
20/08/25	Biotech Growth Trust says court confirms capital reduction	AN
04/06/25	Biotech Growth Trust underperforms benchmark as net asset value falls	AN
04/06/25	The Biotech Growth Trust PLC Reports Earnings Results for the Full Year Ended March 31, 2025	CI
04/06/25	Tranche Update on The Biotech Growth Trust PLC's Equity Buyback Plan announced on July 19, 2024.	CI
27/11/24	Biotech Growth Trust outperforms benchmark but notes currency drag	AN
27/11/24	The Biotech Growth Trust PLC Reports Earnings Results for the Half Year Ended September 30, 2024	CI
19/07/24	The Biotech Growth Trust PLC commences an Equity Buyback Plan for 4,929,790 shares, representing 14.90% of its issued share capital, under the authorization approved on July 18, 2024.	CI
19/07/24	The Biotech Growth Trust PLC initiates a Market Repurchase.	CI
18/07/24	The Biotech Growth Trust PLC's Equity Buyback announced on July 22, 2022 has expired.	CI
05/06/24	Biotech Growth Trust sighs relief as sharply outperforms benchmark	AN
05/06/24	Biotech Growth Trust beats benchmark	AN
05/06/24	The Biotech Growth Trust PLC Reports Earnings Results for the Full Year Ended March 31, 2024	CI
26/03/24	Biotech Group Acquisition Withdraws IPO	DJ
10/11/23	Biotech Growth's total return underperforms benchmark in tough market	AN
09/11/23	The Biotech Growth Trust PLC Reports Earnings Results for the Half Year Ended September 30, 2023	CI
15/06/23	Biotech Growth Trust net assets drop after "another difficult year"	AN